Advertisement

Topics

Jerry Cott, Ph.D Company Profile

13:06 EDT 25th September 2018 | BioPortfolio

Jerry is a neuropsychopharmacologist specializing in clinical and preclinical psychotherapeutic drug development. Since obtaining his Ph.D. in pharmacology at the University of North Carolina in Chapel Hill, and a postdoctoral fellowship with Nobel Laureate, Arvid Carlsson, at the University of Göteborg, Sweden, he has had a variety of work experiences including: teaching medical school at the University of Ibadan in Nigeria; clinical and pharmacology/toxicology review for Investigational New Drugs at the FDA; and 8 years in the pharmaceutical industry in the U.S. and Sweden. Jerry was Chief of the Psychopharmacology Research Program at the National Institute of Mental Health from 1991 until June 2000. He was recently appointed Scientific Advisor to the Institute of Mental Health Research at the Royal Ottawa Hospital in Canada and is on the Advisory Board of the American Botanical Council and the Editorial Board of the Journal of Alternative and Complementary Medicine and the Journal of American Herbals Guild. He has been a member of the NIH Initial Review Group of the National Center for Complementary and Alternative Medicine (NCCAM). Jerry initiated the 1998 NIH workshop entitled “Omega-3 fatty essential fatty acids and psychiatric disorders” and the NIH multicenter controlled clinical trials of St. John’s wort in major depression, Ginkgo biloba in senile dementia, and the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). His present interest is in the integration of mainstream psychiatry with nutritional and botanical interventions for the treatment of severe and chronic mental disorders. He has written articles on the importance of essential fatty acids for mental health and during pregnancy and on the antidepressant effects of St. John's Wort. He is a member of the Bahá'í Faith, a world-wide religion that affirms the fundamental importance of nutritional and spiritual components of healing as well as conventional medicine in the treatment and prevention of disease.

Location

9002 Acredale Ct
College Park
Maryland
20740-4001
United States of America

Contact

Phone: 202/746-9693
Email: alkaloid@NOSPAMjerrycott.com


News Articles [47 Associated News Articles listed on BioPortfolio]

The lost art of reassurance medicine

Jerry and his wife, Pam, were not “medical people” and wouldn’t be considered high achievers. They seemed to be taking life in stride with a “mom and pop” disposition. Jerry had Alzheimer’...

Gerald “Jerry” M Reaven: the “father of insulin resistance”

Gerald “Jerry” M Reaven was a pioneer in insulin research, whose discoveries formed the basis of the concept of metabolic syndrome. He is credited with developing the first quantitative method to....

California at 'war' with Washington over immigration: governor

California Governor Jerry Brown accused the Trump administration Wednesday of launching a war over the state's protections for illegal immigrants, after the Justice Department sued to block its sanctu...

Trivedi Global CEO Vitamin D is Key Author Alice Branton Talks Thyroid Disease on NBC Daytime with Jerry Penacoli

TAMPA, Fla. (PRWEB) August 31, 2018 Alice Branton shared her personal story on NBC Daytime about how her thyroid auto-immune disease...

Miami-LSU with the #1 Canes fan (my mom) at Jerry’s World in Dallas. Go Canes! #ItsAllAboutTheUpic.twitter.com/90uvc27OOj

Miami-LSU with the #1 Canes fan (my mom) at Jerry’s World in Dallas. Go Canes! #ItsAllAboutTheU pic.twitter.com/90uvc27OOj

This Morning's Technical Outlook on Beverages Stocks -- Coca-Cola European Partners, Cott, Dr ...

www.wallstequities.com/registration Coca-Cola European Partners Uxbridge, the UK-based Coca-Cola European Partners PLC's stock finished Friday's session 0.81% lower at $40.55. A total volume of ...

Neos Therapeutics Appoints Jerry McLaughlin as Chief Executive Officer

DALLAS and FORT WORTH, Texas, June 27, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative e...

Matinas Biopharma Holdings' (MTNB) CEO Jerry Jabbour on Q1 2018 Results - Earnings Call Transcript

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [18 Associated Companies listed on BioPortfolio]

Jerry Cott, Ph.D

Jerry is a neuropsychopharmacologist specializing in clinical and preclinical psychotherapeutic drug development. Since obtaining his Ph.D. in pharmacology at the University of North Carolina in Chape...

Jerry’s House

Dr. Jerry Weichman

Jerry's House

Jerry Lewis MDA Telethon

More Information about "Jerry Cott, Ph.D" on BioPortfolio

We have published hundreds of Jerry Cott, Ph.D news stories on BioPortfolio along with dozens of Jerry Cott, Ph.D Clinical Trials and PubMed Articles about Jerry Cott, Ph.D for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Jerry Cott, Ph.D Companies in our database. You can also find out about relevant Jerry Cott, Ph.D Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Mental Health
Adhd Anorexia Depression Dyslexia Mental Health Psychiatry Schizophrenia Stress Mental health, although not being as obvious as physical health, is very important, causing great unhappiness to those affected, causing add...


Corporate Database Quicklinks



Searches Linking to this Company Record